InsiderClue
← All stocks

Avalyn Pharma Inc.

AVLN Net buying
CIK 0001540171 #2181 in the set updated 17 Sep 2026
Bought (12 mo)
$25.00M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$25.00M
+$25.00M against sales at will

By person

5 insiders · 4 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Novo Holdings A/S entity
10% owner
$10.00M (1)
—
+$10.00M
3,883,289
8.76%
$69.90M
—
SR ONE CAPITAL MANAGEMENT, LLC entity
10% owner
$10.00M (2)
—
+$10.00M
1,122,087
2.53%
$20.20M
—
Carroll Jill
Director
$5.00M (1)
—
+$5.00M
2,186,562
4.93%
$39.36M
—
FMR LLC entity
10% owner
—
—
—
2,284,535
5.15%
$41.12M
—
Wellington Biomedical Innovation Master Investors (Cayman) II L.P.
10% owner
—
—
—
1,275,486
2.88%
$22.96M
—

Individual transactions

4
Insider
Date
Role
Action
Shares
Price
Amount
SR ONE CAPITAL MANAGEMENT, LLC
1 May 2026
10% owner
Buy indirect
277,777
$18.00
$5.00M
SR ONE CAPITAL MANAGEMENT, LLC
1 May 2026
10% owner
Buy indirect
277,778
$18.00
$5.00M
Carroll Jill
1 May 2026
Director
Buy indirect
277,778
$18.00
$5.00M
Novo Holdings A/S
1 May 2026
10% owner
Buy
555,555
$18.00
$10.00M
Show all 4 transactions →

What was left out

Form 4 filings counted 14
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 11,549,633
History held since 1 May 2026